The really, really early warning requirement for new drugs has prompted the predictable response from the usual suspects. The goal of course is to focus post market detective work on which groups of people respond best to which drugs. But that's not how it's playing out. PhRMA fears people will worry unnecessarily and safety-uber-alles zealots like Diane Zuckerman, president of the National Research Center for Women and Families, worries "It's not going to say how many reports there were. It's not going to say how many died and how many were hospitalized."
Oh. And just how high a body count would Diane like? I have a clue.
Diane, has also said that anti-depressants don't work and that she knew better than I did because she is an epidemiologist, When I told her that certain members of my family had responded well to SSRIs she said, "Well, good for you. " I could feel the love.
http://ap.google.com/article/ALeqM5jLeef2T5nlybcAAzF3Fe1qqDEaqgD930MUEG0
Like I said, predictable.
Oh. And just how high a body count would Diane like? I have a clue.
Diane, has also said that anti-depressants don't work and that she knew better than I did because she is an epidemiologist, When I told her that certain members of my family had responded well to SSRIs she said, "Well, good for you. " I could feel the love.
http://ap.google.com/article/ALeqM5jLeef2T5nlybcAAzF3Fe1qqDEaqgD930MUEG0
Like I said, predictable.
